155 related articles for article (PubMed ID: 31085008)
41. Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma.
Zhang J; Sun G; Mei X
Cancer Biomark; 2019; 26(3):367-373. PubMed ID: 31594212
[TBL] [Abstract][Full Text] [Related]
42. FOXM1 predicts disease progression in non-muscle invasive bladder cancer.
Rinaldetti S; Wirtz R; Worst TS; Hartmann A; Breyer J; Dyrskjot L; Erben P
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1701-1709. PubMed ID: 29959570
[TBL] [Abstract][Full Text] [Related]
43. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer.
Zhang HG; Xu XW; Shi XP; Han BW; Li ZH; Ren WH; Chen PJ; Lou YF; Li B; Luo XY
Clin Transl Oncol; 2016 May; 18(5):527-32. PubMed ID: 26370421
[TBL] [Abstract][Full Text] [Related]
45. FoxM1 inhibition enhances chemosensitivity of docetaxel-resistant A549 cells to docetaxel via activation of JNK/mitochondrial pathway.
Wang K; Zhu X; Zhang K; Zhu L; Zhou F
Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):804-9. PubMed ID: 27521795
[TBL] [Abstract][Full Text] [Related]
46. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
[TBL] [Abstract][Full Text] [Related]
47. Prognostic and clinicopathological value of FoxM1 expression in colorectal cancer: A systematic review and meta-analysis.
Yao Y; Wang X; Jiang L; Shao X; Zhu X; He S
Medicine (Baltimore); 2018 Dec; 97(52):e13899. PubMed ID: 30593202
[TBL] [Abstract][Full Text] [Related]
48. Enhanced expression of long non-coding RNA ZXF1 promoted the invasion and metastasis in lung adenocarcinoma.
Zhang L; Zhou XF; Pan GF; Zhao JP
Biomed Pharmacother; 2014 May; 68(4):401-7. PubMed ID: 24721325
[TBL] [Abstract][Full Text] [Related]
49. Rab27b Is a Potential Indicator for Lymph Node Metastasis and Unfavorable Prognosis in Lung Adenocarcinoma.
Zhang L; Fan W; Xu L; Mao Q; Chen Y; Mao Y; Xu L; Wang J
Dis Markers; 2018; 2018():7293962. PubMed ID: 30627227
[TBL] [Abstract][Full Text] [Related]
50. Clinical value and potential association of Rab1A and FoxM1 aberrant expression in colorectal cancer.
Xu M; Shao X; Li H; Zhang Z; Zhou C; Cheng Z
Sci Rep; 2020 Nov; 10(1):20160. PubMed ID: 33214609
[TBL] [Abstract][Full Text] [Related]
51. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
Wang W; Ren S; Wang Z; Zhang C; Huang J
Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
[TBL] [Abstract][Full Text] [Related]
52. Clinical significance of nuclear localisation of agrin in lung adenocarcinoma.
Li D; Gu Q; Xie Z; Shen Q; Li H
Pol J Pathol; 2019; 70(3):198-204. PubMed ID: 31820863
[TBL] [Abstract][Full Text] [Related]
53. ADAM-17 expression is enhanced by FoxM1 and is a poor prognostic sign in gastric carcinoma.
Fang W; Qian J; Wu Q; Chen Y; Yu G
J Surg Res; 2017 Dec; 220():223-233. PubMed ID: 29180185
[TBL] [Abstract][Full Text] [Related]
54. Expression profile, clinical significance, and biological function of insulin-like growth factor 2 messenger RNA-binding proteins in non-small cell lung cancer.
Shi R; Yu X; Wang Y; Sun J; Sun Q; Xia W; Dong G; Wang A; Gao Z; Jiang F; Xu L
Tumour Biol; 2017 Apr; 39(4):1010428317695928. PubMed ID: 28381175
[TBL] [Abstract][Full Text] [Related]
55. Fibulin-1 functions as a prognostic factor in lung adenocarcinoma.
Cui Y; Liu J; Yin HB; Liu YF; Liu JH
Jpn J Clin Oncol; 2015 Sep; 45(9):854-9. PubMed ID: 26185140
[TBL] [Abstract][Full Text] [Related]
56. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo].
Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH
Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822
[TBL] [Abstract][Full Text] [Related]
57. LncRNA TTN-AS1 drives invasion and migration of lung adenocarcinoma cells via modulation of miR-4677-3p/ZEB1 axis.
Zhong Y; Wang J; Lv W; Xu J; Mei S; Shan A
J Cell Biochem; 2019 Oct; 120(10):17131-17141. PubMed ID: 31173403
[TBL] [Abstract][Full Text] [Related]
58. FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer.
Breyer J; Wirtz RM; Erben P; Rinaldetti S; Worst TS; Stoehr R; Eckstein M; Sikic D; Denzinger S; Burger M; Hartmann A; Otto W
BJU Int; 2019 Jan; 123(1):187-196. PubMed ID: 30120861
[TBL] [Abstract][Full Text] [Related]
59. Development and validation of a RNA binding protein-associated prognostic model for lung adenocarcinoma.
Li W; Gao LN; Song PP; You CG
Aging (Albany NY); 2020 Feb; 12(4):3558-3573. PubMed ID: 32087603
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of forkhead box M1 is associated poor survival in patients with nonsmall cell lung cancer.
Liu B; Su F; Lin R; Teng H; Ju Y
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1121-S1123. PubMed ID: 30539856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
